Page last updated: 2024-11-12

agn 192403

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

AGN 192403: a potent imidazoline receptor specific agent; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11957452
SCHEMBL ID1765147
MeSH IDM0258799

Synonyms (20)

Synonym
EU-0100109 ,
agn 192403 hydrochloride
A-252
(2-endo,3exo)-3-(methylethyl)-bicyclo[2.2.1]heptan-2-amine hydrochloride
175521-95-6
SCHEMBL1765147
1021868-90-5
(+/-)-2-endo-amino-3-exo-isopropylbicyclo[2.2.1]heptane hydrochloride
AKOS024456370
agn192403 hydrochloride;agn-192403 hydrochloride
J-011118
SR-01000075245-1
sr-01000075245
SR-01000075245-3
3-(propan-2-yl)bicyclo[2.2.1]heptan-2-amine hydrochloride
agn192403hydrochloride
agn192403;agn-192403
agn 192403
3-isopropylbicyclo[2.2.1]heptan-2-amine hydrochloride
3-propan-2-ylbicyclo[2.2.1]heptan-2-amine;hydrochloride
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (10.00)18.2507
2000's8 (80.00)29.6817
2010's1 (10.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.48

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.48 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.70 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.48)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]